Navigation Links
Women's Gynecological Exams: Another Victim of the Troubled Economy?
Date:5/5/2009

New Survey From National Ovarian Cancer Coalition Says Gynecologic Health Exams Likely To Fall To The Wayside Due To Economic Factors

DALLAS, May 5 /PRNewswire/ -- At Mother's Day, a new survey from the National Ovarian Cancer Coalition (NOCC), www.ovarian.org, reveals some startling facts about women's health: more than 52 percent of women expect the economy will impact their gynecological health choices, in many cases delaying or skipping their annual gynecological exams altogether.

Fielded by TNS Global for the NOCC, the study surveyed 1,000 Americans on their awareness of ovarian cancer, a leading gynecologic cancer. Ovarian cancer affects 20,000 women annually and is responsible for the deaths of 15,000 each year. Older women are at highest risk. Additionally, about two-thirds of ovarian cancer deaths occur in women aged 55 and over and about 25 percent occur in women between 35 and 54*, according to the National Institutes of Health.

Significant results from the survey include:

  • One in three women has not had a gynecologic exam in the past year.
  • 28.5 percent will skip seeing a gynecologist and will only see their primary care physician.
  • 23.2 percent will only get their annual exam if they have a problem.
  • 14.2 percent will delay their annual exam altogether.

"These results are particularly troubling to the NOCC due to the nature of ovarian cancer, the fact that women are not seeing their physicians for an annual exam and the lack of awareness of symptoms," said Carol Ansley, CEO of the NOCC. "There is no screening test, so women need to be their own advocates and have an open dialogue with their health practitioners about persistent symptoms. With ovarian cancer, early detection is key to long-term survival. Improved survival rates come from continuing to educate women about early signs and symptoms."

Women should pay heed to the following symptoms:

  • Upset stomach or heartburn
  • Unexplained weight loss or gain
  • Fatigue
  • Menstrual changes
  • Pain during intercourse
  • Back pain
  • Constipation

Women who have these symptoms almost daily for more than a few weeks should consult their physician, preferably a gynecologist. Persistence of symptoms is key, especially when the symptoms do not resolve with normal interventions such as diet change, exercise, rest, etc. Also, a Pap test does not detect ovarian cancer, so additional testing will need to be done by a health practitioner to make a diagnosis. This could include a pelvic exam, transvaginal ultrasound or a blood test.

The National Ovarian Cancer Coalition is a 501 (c)(3) charitable organization that provides public education and awareness about ovarian cancer through a toll-free Help Line, local NOCC Chapters, comprehensive website, peer support, publications, and awareness/educational programs. NOCC's mission is to raise awareness and promote education about ovarian cancer. The Coalition is committed to improving the survival rate and quality of life for women with ovarian cancer. For more information on the "Break the Silence" campaign and to contact one of the local NOCC Chapters, visit www.ovarian.org or call 1-888-OVARIAN.

*Source: National Library of Medicine - www.nlm.nih.gov/medlineplus/ency/article/000889.htm


'/>"/>
SOURCE National Ovarian Cancer Coalition
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Womenshealthchannel Enhancements Support Pregnant Teens
2. Another Reason Not to Smoke While Pregnant: Birth Defects
3. One Species Genome Found Within Another
4. Eat Seafood, See Weight Loss: Recent Study Finds Another Reason to Eat Seafood for a Fit Lifestyle
5. Message for Activists at Latino National Congreso Convention: Amnesty Will Exacerbate National Problems and Turn the U.S. into Another Mexico
6. Latest Edition of Ripon Forum Highlights Schwarzeneggers Leadership on Another Challenge Facing his State - Health Care
7. Beckman Coulter Signs Agreements With Amerinet, Inc.; Ten-Year Partnership Extended for Another Three Years
8. Portico(TM) Systems Charts Another Period of Rapid Growth
9. Another Medtronic Sprint Fidelis Lead Lawsuit is Filed in Federal District Court
10. FDA Sunscreen Labeling Decision Delayed Another Month, Leading U.S. Physician to Say, Enough Is Enough
11. Another smart cancer drug can have toxic effects on the heart
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... , ... April 28, 2017 , ... ... announce the integration of Microsoft(R) Word(TM) Online(TM), which enables sleep physicians to create ... it streamlines the reporting process and provides a familiar interface that does not ...
(Date:4/28/2017)... ... ... sleep affects much more than energy – it also has mental and physical benefits. According ... reaction time, which can increase the risk of having a car accident. , This ... NSF to help you sleep better and feel better:, , Turn ...
(Date:4/28/2017)... ... April 28, 2017 , ... Ushio America proudly ... offer an instant energy-saving solution for F32T8 fluorescent lamps on most instant-start and ... These 50,000 hour rated lamps utilize the existing electronic ballast, saving labor and ...
(Date:4/28/2017)... ... April 28, 2017 , ... ... exposed to more adverse experiences than children in the general population. That’s because ... abuse, neglect or other family challenges. While no fault of their own, youth ...
(Date:4/28/2017)... ... April 28, 2017 , ... Early detection ... improve drug safety and minimize the cost of development. In this webinar, sponsored ... using cell lines and for cardiac toxicity using induced pluripotent stem cells (iPSCs). ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... 20, 2017  RXi Pharmaceuticals Corporation (NASDAQ: RXII), ... address significant unmet medical needs, today announced that ... consumer product development program, based on its proprietary ... Investigative Dermatology (SID) 76 th Annual Meeting.  ... the sciences relevant to skin health and disease ...
(Date:4/20/2017)... 20, 2017   ZappRx, Inc ., a digital health ... process, today announced it closed $25 million in Series B ... firm based in Seattle that is ... . The Series B round included participation from SR ... and GV (formerly Google Ventures). As part of ...
(Date:4/20/2017)... -- Eyevensys, a private biotechnology company developing ... technology that enables the safe, local, sustained production of ... range of ophthalmic diseases, announces it has received approval ... (MHRA) to advance its technology into clinical development. ... The EyeCET platform ...
Breaking Medicine Technology: